Intensifying Downstream Bioprocessing With Continuous Technologies

The shift from traditional batch processes to intensified continuous processes is more than just a trend—it's the future of monoclonal antibody (mAb) production. Cytiva recognizes the need for more cost-effective and efficient solutions in this field.

This webinar explores intensified downstream bioprocessing in depth, covers common bottlenecks, and introduces continuous processing solutions capable of transforming your mAb platform. Discover how to streamline your polishing step with single flow-through chromatography or boost efficiency using single-pass Tangential Flow Filtration (TFF). Further, gain insight into strategies to intensify capture chromatography and viral inactivation for unparalleled outcomes.

Watch to take a step toward a more innovative and efficient future in bioprocessing.